Fabienne Willaert
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.
Journal: The Lancet regional health. Europe
Published: January 29, 2026
Early Use of Beneficial Biological Therapy on Younger Psoriasis Patients: Could a 'Step-Down' Therapy Approach Be More Effective?
Journal: International journal of dermatology
Published: January 14, 2025
The doctor will see you now, in 4 months: A Belgian perspective on waiting times for dermatologic care.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 22, 2024
Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients.
Journal: Dermatology (Basel, Switzerland)
Published: December 10, 2023
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.
Journal: JAAD international
Published: August 19, 2021
Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment.
Journal: Frontiers in immunology
Published: February 26, 2021
Real-life effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 15, 2020
Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 2).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 02, 2020
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 02, 2020
A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 29, 2019
Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa.
Journal: Case reports in dermatology
Published: October 09, 2017
Last Updated: 09/26/2026